CDC published a notice that a proposed collection of information project entitled “Prevention Research Centers Program National Evaluation Reporting System” has been submitted to OMB for review and approval. Comments will be accepted for 60 days following publication. The notice, available here, appeared in the December 14 Federal Register.

CDC published a notice that a proposed collection of information project entitled “School Associated Violent Death Surveillance System” has been submitted to OMB for review and approval. Comments will be accepted for 60 days following publication. The notice, available here, appeared in the December 14 Federal Register.

CDC published a request for information and comment entitled “Silver Nanoparticles (AgNPs).” Comments will be accepted for 60 days following publication. The notice, available here, appeared in the December 19 Federal Register.

CDC published a notice that a proposed collection of information project entitled “National Intimate Partner and Sexual Violence Surveillance System” has been submitted to OMB for review and approval. Comments will be accepted for 60 days following publication. The notice, available here, appeared in the December 19 Federal Register.

CDC published a notice that a proposed collection of information project entitled “Prevention Research Centers Program National Evaluation Reporting System” has been submitted to the OMB for review and approval. Comments will be accepted for 60 days following publication. The notice, available here, appeared in the December 19 Federal Register.

CDC published a notice that a proposed collection of information project entitled “Evaluation of the Get Yourself Tested (GYT) Campaign” has been submitted to OMB for review and approval. Comments will be accepted for 30 days following publication. The notice, available here, appeared in the December 19 Federal Register.

CDC published a notice that a proposed collection of information project entitled “Million Hearts™ Hypertension Control Challenge” has been submitted to OMB for review and approval. Comments will be accepted for 60 days following publication. The notice, available here, appeared in the December 19 Federal Register.

CMS published a notice correcting technical errors that appeared in a final rule entitled “Medicaid Program; Payments for Services Furnished by Certain Primary Care Physicians and Charges for Vaccine Administration Under the Vaccines for Children Program [CMS-2370-P]” that was published in the November 6, 2012 Federal Register. This final rule becomes effective on January 1, 2013. The notice, available here, appeared in the December 14 Federal Register.

FDA published a notice announcing the establishment of a docket and request for comments and information concerning the relevance of conducting a risk assessment to establish regulatory thresholds for major food allergens as defined in the Food Allergen Labeling and Consumer Protection Act of 2004. To ensure consideration, comments must be received by the FDA no later than February 12, 2013. The notice, available here, appeared in the December 14 Federal Register.

FDA published a notice announcing an upcoming meeting of the Pulmonary-Allergy Drugs Advisory Committee. The meeting will be held on March 7, 2012 at the FDA White Oak Campus in Silver Spring, MD. The notice, available here, appeared in the December 14 Federal Register.

FDA published a notice that a proposed collection of information project entitled “Information to Accompany Humanitarian Device Exemption Applications and Annual Distribution Number Reporting Requirements” has been submitted to OMB for review and approval. Comments will be accepted for 60 days following publication. The notice, available here, appeared in the December 17 Federal Register.

FDA published a notice extending the expiration date of a policy compliance guide entitled “Radiofrequency Identification Feasibility Studies and Pilot Programs for Drugs [(CPG) Sec. 400.210]. The expiration date has been extended to December 31, 2014. The notice, available here, appeared in the December 17 Federal Register.

FDA published a notice announcing the availability of draft and revised guidance entitled “Draft and Revised Draft Guidances for Industry Describing Product-Specific Bioequivalence Recommendations.” The notice, available here, appeared in the December 17 Federal Register.

FDA published a notice announcing the availability of draft guidance entitled “Draft Guidance for Industry on Enrichment Strategies for Clinical Trials to Support Approval of Human Drugs and Biological Products.” The notice, available here, appeared in the December 17 Federal Register.

FDA published a notice announcing the availability of draft guidance entitled “Draft Guidance for Industry on Certification of Designated Medical Gases.” To ensure consideration, comments must be received no later than February 19, 2013. The notice, available here, appeared in the December 18 Federal Register.

FDA published a notice that a proposed collection of information project entitled “Guidance: Emergency Use Authorization of Medical Products” has been submitted to OMB for review and approval. Comments will be accepted for 30 days following publication. The notice, available here, appeared in the December 19 Federal Register.

FDA published a request for comments entitled “Comprehensive Assessment of the Process for the Review of Device Submissions.” Comments will be accepted for 45 days following publication. The notice, available here, appeared in the December 19 Federal Register.

FDA published a notice announcing the availability of draft guidance entitled “Draft Guidance for Industry on Providing Submissions in Electronic Format--Summary Level Clinical Site Data for Center for Drug Evaluation and Research’s Inspection Planning.” To ensure consideration, comments must be submitted no later than February 19, 2013. The notice, available here, appeared in the December 19 Federal Register.

FDA published a notice announcing an upcoming public meeting of the Drug Safety and Risk Management Advisory Committee. The meeting will be held January 24-25, 2013 at the FDA White Oak Campus in Silver Spring, MD. The notice is available here and appeared in the December 19 Federal Register.

FDA published a notice announcing an upcoming public hearing entitled “Impact of Approved Drug Labeling on Chronic Opioid Therapy” and request for comments. The hearing will be held February 7-8, 2013 in Bethesda, MD. Comments will be accepted until April 8, 2013. The notice is available here and appeared in the December 19 Federal Register.

FDA put on display a notice announcing the availability of two guidance documents entitled “Guidances for Industry and Investigators on Safety Reporting Requirements for Investigational New Drug Applications and Bioavailability/ Bioequivalence Studies” and “Small Entity Compliance Guide.” The notice, available here, is scheduled to appear in the December 20 Federal Register.

HHS published a notice announcing an upcoming public meeting of the Advisory Council on Alzheimer’s Research, Care and Services. The meeting will be held on January 14, 2013 at HHS Headquarters in Washington, DC.

Preregistration is required. The notice, available here, appeared in the December 17 Federal Register.

HRSA put on display a notice that a proposed collection of information project entitled “The National Health Corps Travel Request” has been submitted to the OMB for review and approval. Comments will be accepted for 30 days following publication. The notice, available here, is scheduled to appear in the December 20 Federal Register.

SAMHSA published a notice that a proposed collection of information project entitled “Services Accountability Improvement” has been submitted to OMB for review and approval. Comments will be accepted for 60 days following publication. The notice, available here, appeared in the December 18 Federal Register.

SAMHSA published a notice that a proposed collection of information project entitled “Transformation Accountability Reporting System” has been submitted to OMB for review and approval. Comments will be accepted for 60 days following publication. The notice, available here, appeared in the December 18 Federal Register.

SAMHSA published a notice that a proposed collection of information project entitled “Site Visits with Grantees Integrating HIV Primary Care, Substance Abuse, and Behavioral Health Services” has been submitted to OMB for review and approval. Comments will be accepted for 30 days following publication. The notice, available here, appeared in the December 19 Federal Register.